Fertility Preservation in Cancer Patients

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 47 Minutes

Overview

This program offers a comprehensive overview of fertility preservation in patients diagnosed with cancer. Participants will explore indications for fertility preservation, methods to assess reproductive potential, and the logistics and timing of oocyte, embryo, sperm, and tissue cryopreservation. Through case-based discussions, attendees will gain practical insights into counseling patients, coordinating care before gonadotoxic therapy, and understanding future pregnancy outcomes to support informed, patient-centered decision‑making.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

  1. Identify indications for fertility preservation in patients newly diagnosed with cancer
  2. Describe diagnostic tests used to assess fertility and how these tests inform fertility treatment decisions
  3. Review the logistics, timing, and cryopreservation process for oocytes, embryos, and sperm prior to gonadotoxic cancer treatment 
  4. Discuss the potential future pregnancy rates following cryopreservation                                                       
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
01/20/2026
Course expires: 
01/23/2027
Cost:
$0.00
Rating: 
0

Faculty

Joseph Letourneau, MD 

Co-Director University of Utah Onco-Fertility Program
Utah Center for Reproductive Medicine
Salt Lake City, UT

Dr. Letourneau is an Assistant Professor of Reproductive Endocrinology and Infertility at the University of Utah, where he serves as co-director of the University of Utah’s Oncofertility Program. The University of Utah’s oncofertility clinic serves as a referral center for the Intermountain West, including cities and rural areas in Utah, Nevada, Idaho, Montana, Wyoming, Western Colorado and Northern Arizona. Dr. Letourneau is an active clinician-researcher. He is former ASRM/NICHD CREST Scholar and recent recipient of an ASRM Young Investigator Grant.

Dr. Letourneau has published over 75 research articles and abstracts in the field of oncofertility. He has served as an expert advisor to the U.S. Food and Drug Administration regarding fertility concerns around cancer drug development. He also serves on the American Society of Clinical Oncology’s Fertility Preservation Guidelines advisory committee. Lastly, Dr. Letourneau had worked to help to ensure more universal insurance coverage for oncofertility services, including recently helping to make Utah the second state in the U.S. to cover oncofertility services under their state’s Medicaid plan.

 

Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Joseph Letourneau, MD   declares the following financial relationships: Consulting Fee: EMD Serono during the past 24 months..

Available Credit

  • 0.75 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test
  4. Submit the evaluation form

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above